Soleno Therapeutics, Inc.SLNONASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank100
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
14.91%
↑ 103% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthStrong
Average
-452.45%
Historical baseline
PeriodValueYoY Change
TTM14.91%-
20240.00%-
20230.00%-
20220.00%-
20210.00%-
20200.00%-
20190.00%-100.0%
20170.52%+100.1%
2016-463.05%+88.6%
2015-4076.92%-